Antibiotic resistance in Lactobacillus reuteri and Lactobacillus plantarum by Egervärn, Maria
Antibiotic Resistance in Lactobacillus 
reuteri and Lactobacillus plantarum 
 
Maria Egervärn 
Faculty of Natural Resources and Agricultural Sciences 
Department of Microbiology 
Uppsala
Doctoral Thesis 
Swedish University of       Agricultural Sciences 
Uppsala 2009  
Acta Universitatis agriculturae Sueciae 
2009: 30 
ISSN 1652-6880 
ISBN 978-91-86195-77-9 
© 2009 Maria Egervärn, Uppsala 
Tryck: SLU Service/Repro, Uppsala 2009 
Cover: Antibiotic susceptibility testing by Etest (left; photo: M. Egervärn) and 
broth  microdilution  (right;  reproduced  with  the permission of the National 
Veterinary Institute, Uppsala, Sweden).   3 
Antibiotic  Resistance  in  Lactobacillus  reuteri  and  Lactobacillus 
plantarum 
Abstract 
Lactic acid bacteria (LAB) may act as reservoirs of antibiotic resistance genes that can 
be transferred via the food chain or within the gastrointestinal tract to pathogenic 
bacteria. This thesis provides data required for assessing the potential risk of using 
antibiotic  resistant  strains  of  the  LAB  species  Lactobacillus  reuteri  and  Lactobacillus 
plantarum as food processing aids or probiotics. Knowledge of the distributions of 
antibiotic minimum inhibitory concentrations (MICs) for a species is needed when 
using  a  phenotypic  method  to  differentiate  strains  with  acquired  resistance  from 
susceptible strains or strains with intrinsic resistance. Controlled and standardised 
conditions are required for antibiotic susceptibility testing of LAB, as demonstrated 
here during evaluation of the Etest and broth microdilution MIC determination 
methods  used.  Inoculum  size  and  incubation  time  were  varied  during  broth 
microdilution testing of the susceptibilities of 35 LAB strains to six antibiotics. An 
increase in either parameter resulted in elevated MICs for all species. 
Antibiotic  susceptibility  profiles  were  determined  for  56  L. reuteri  and  121 
L. plantarum strains that differed by source and spatial and temporal origin. MIC data 
obtained with the Etest and the broth microdilution methods corresponded well 
with each other. All L. plantarum strains were susceptible to ampicillin, gentamicin, 
erythromycin and clindamycin, and intrinsically resistant to streptomycin. Acquired 
resistance to tetracycline was associated with plasmid-bound tet(M). 
Lactobacillus reuteri strains had acquired resistance to tetracycline (n=28), ampicillin 
(n=14),  erythromycin/clindamycin  (n=6)  and  chloramphenicol  (n=1).  This 
resistance was attributed to mutational pbp genes for ampicillin and to added tet(W), 
erm  and  cat(TC)  genes  for  the  antibiotics  inhibiting  protein  synthesis.  Genetic 
relatedness was observed among L. reuteri strains with high MICs for both ampicillin 
and  tetracycline  and  among  strains  with  high  MICs  for  both  erythromycin  and 
clindamycin.  The  majority  of  the  antibiotic  resistant  L. reuteri  strains  carried  the 
resistance genes on plasmids. Traits of putative transfer machineries adjacent to both 
plasmid- and chromosome-located resistance genes were demonstrated.  
Lactobacillus reuteri as a donor of resistance genes in the human gut was investigated 
by  studying the transferability of the tetracycline resistance gene tet(W) to faecal 
enterococci,  bifidobacteria  and  lactobacilli.  No  gene  transfer  was  demonstrated 
under the conditions tested. 
Keywords: Lactobacillus reuteri, Lactobacillus plantarum, antibiotic susceptibility testing, 
MIC,  tetracycline  resistance,  tet  genes,  erythromycin  resistance,  erm  genes,  gene 
transferability. 
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1  Introduction 
Lactic acid bacteria (LAB), like all other bacteria, can exchange genes to 
enhance their survival in antibiotic-containing habitats (Teuber et al., 1999). 
The close contact between LAB and other bacteria, e.g. in the intestine, on 
mucosal surfaces or in food, is a precondition for horizontal gene transfer by 
mobile  genetic  elements.  Ingested  and  indigenous  LAB  may  therefore 
contribute to the pool of antibiotic resistance genes that can be transferred 
via the food chain or within the gastrointestinal tract to other commensal 
bacteria or to pathogens (Teuber et al., 1999; Salyers et al., 2004). 
Antibiotic  resistance  of  LAB  used  for  food,  feed  and  probiotic 
applications has recently been proposed as a hazard due to the potential risk 
for  transfer  to  pathogenic  bacteria.  The  European  Commission  has,  as 
advised  by  the  European  Food  Safety  Authority  (EFSA),  requested  that 
bacterial  strains  harbouring  transferable  antibiotic  resistance  genes  should 
not be used in animal feeds (European Parliament and Council Regulation 
EC  429/2008;  EC,  2001).  No  legislation  exists  so  far  regarding 
microorganisms intentionally added to fermented food and probiotics for 
human  use.  However,  based  on  the  precautionary  principle,  it  is 
recommended  that  these  products  follow  similar  requirements  to  feed 
additives  (EFSA,  2007).  Measures  based  on  this  principle  should  be 
considered provisional until more comprehensive data concerning the risk 
are obtained and analysed. 
The  present  investigation  was  initially  performed  as  part  of  the  EU 
project  ACE-ART  (CT-2003-506214;  Morelli,  2008),  which  aimed  to 
assess and critically evaluate antibiotic resistance transferability in the food 
chain. The intention was to obtain data related to phenotypic susceptibility 
testing,  identification  and  characterisation  of  resistance  genes  and  the 
potential for gene transferability of different LAB species, and through this 
prove or discount the current strategy based on the precautionary principle.   12 
1.1  Aims 
The overall aim of this thesis was to provide data required for assessing the 
potential  risk  of  using  antibiotic  resistant  strains  of  the  LAB  species 
Lactobacillus reuteri and Lactobacillus plantarum as starter cultures or probiotics. 
Specific objectives were to: 
 
  Evaluate  the  effects  of  inoculum  size  and  incubation  time  on  the 
antibiotic susceptibilities of LAB using a broth microdilution method 
(I),  and  compare  minimum  inhibitory  concentration  (MIC)  data 
obtained by broth microdilution with an Etest method (II and III). 
   Determine antibiotic susceptibility profiles of L. reuteri of animal and 
human origin (II) and L. plantarum of dairy and vegetable origin (III).  
  Investigate the genetic relatedness of the L. reuteri strains with atypical 
antibiotic MICs (II). 
  Identify  and  characterise  the  resistance  genes  mediating  atypical 
antibiotic MICs in L. reuteri and L. plantarum (IV). 
   Investigate the transferability of an antibiotic resistance gene from a 
probiotic L. reuteri strain to bacteria in the intestinal tract of humans 
(V).   13 
2  Antibiotic resistance 
The  rapid  emergence  of  antibiotic  resistant  bacteria  is  a  major  threat  to 
public  health  (ECDC, 2007; WHO, 2007b), the obvious concern being 
that  infections  might  no  longer  be  treatable  with  antibiotics.  Effective 
antibiotics  are  also  essential  tools  for  organ  transplantation,  cancer 
chemotherapy and orthopaedic surgery (Cars et al., 2008). Surveillance data 
have  shown  an  increasing  incidence  of  infections  caused  by  antibiotic 
resistant  pathogens  in  many  countries  (EARSS,  2007).  For  example,  the 
prevalence in blood cultures of Klebsiella pneumoniae producing extended-
spectrum  betalactamases  has  now  approached  50%  in  some  regions  of 
Eastern Europe (EARSS, 2007). In Sweden too, an increase in antibiotic 
resistant bacteria has occurred during recent years (Fig. 1). However, the 
situation here is better than in most other countries. 
  Failure of antibiotic treatment for an infection usually leads to serious 
consequences for the patient and is associated with increased health care 
costs for society. In a recent study of more than 1800 Tanzanian children 
with  signs  of  systemic  infection,  the  mortality  rate  from  Gram-negative 
bloodstream  infections  was  more  than  double  that  of  malaria  (44% 
compared  with  20%)  (Blomberg  et  al.,  2007).  Two  American  studies 
showed that the mortality rate from bacteraemia and the hospital costs for 
surgery-related infections were both on average twice as high for patients 
infected  with  meticillin  resistant  Staphylococcus  aureus  than  for  patients 
infected  with  meticillin  susceptible  bacteria  (Cosgrove  et  al.,  2003; 
Engemann et al., 2003).  
In  addition,  only  two  new  antibiotic  classes  (oxazolidinones  and 
lipopeptides) have been developed since the 1960s and few new drugs are 
currently  in  the  pipeline  (Cars  et  al.,  2008).  All this has raised concerns 
about a ‘post-antibiotic era’, a period with no effective antibiotics available. 
Quinolones,  third/fourth-generation  cephalosporins  and  macrolides  were   14 
therefore  recently  classified  by  the  WHO  (2007a)  as  critically  important 
antibiotics  for  which  urgent  risk  management  strategies  are  needed  to 
preserve their efficacy within human medicine. 
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Figure  1.  Number  of  vancomycin  resistant  enterococci  (VRE),  meticillin  resistant 
Staphylococcus  aureus  (MRSA)  and  extended  spectrum  betalactamase-producing 
Enterobacteriaceae (ESBL) notified annually in Sweden 2000-2008. ESBL became notifiable in 
2007 (SMI, 2009). 
2.1  Development of antibiotic resistant bacteria 
The  emergence  of  antibiotic  resistant  bacteria  is  primarily caused by the 
excessive  and  inappropriate  use  of  antibiotics  in  human  and  veterinary 
medicine,  animal  husbandry,  agriculture  and  aquaculture  (Tenover  & 
Hughes, 1996). Antibiotic prescriptions for viral infections and the use of 
broad-spectrum agents such as cephalosporins and fluoroquinolones when 
the bacteria causing the infection are unknown are examples of such misuse. 
Antibiotic exposure selects for resistant bacteria and kills (bactericidal drugs) 
or inhibits the growth (bacteriostatic drugs) of the susceptible population. 
Because  the  same  antibiotic  classes  are  used  in  humans  and  in  animals, 
bacteria and their resistance genes can be disseminated from one host to 
another, e.g. with food as an intermediate between food-producing animals 
and  humans  (Levy,  1997).  Poor  hygiene  in  the  animal  and  human 
environment,  including  primary  production/slaughter,  hospitals  and  the 
community, increases the spread of resistant bacteria, as does the crowding   15 
of  animals  on  farms  and  of  old  and  immunocompromised  people  in 
hospitals  and  nursing  homes.  Increased  travel  and  the  worldwide 
distribution  of  food  are  other  factors  facilitating  the  rapid  global  spread 
(Cars et al., 2008). 
To  reduce  the  development  of  resistant  bacteria  in  food-producing 
animals,  Sweden  was  the  first  country  to  ban  the  use  of  antibiotics  for 
growth promotion (Swedish act SFS 1985:295 on feed). In 1998, veterinary 
Table  1.  Antibiotics,  their  classes,  modes  of  action  and  mechanisms  of  resistance  (modified  from 
Guardabassi & Courvalin, 2006) 
Antibiotic  Class  Mode of action  Major resistance 
mechanism 
Ampicillin  Betalactams  Inhibit 
transpeptidation step 
in peptidoglycan 
synthesis by binding 
to the PBPs 
Betalactamases; 
mutations in the 
PBPs 
Vancomycin  Glycopeptides  Bind to D-Ala-D-Ala 
peptidoglycan 
precursors, making 
them inaccessible to 
the PBPs 
Peptidoglycan 
precursors 
terminating by 
D-Ala-D-lactate 
Streptomycin, 
amikacin, 
gentamicin, 
kanamycin, 
neomycin 
Aminoglycosides  Bind 30S ribosomal 
subunit 
Aminoglycoside 
modifying enzymes 
Linezolid  Oxazolidinones  Bind 30S ribosomal 
subunit 
Mutation of 23S 
rRNA 
/Oxy/tetracycline  Tetracyclines  Bind 30S ribosomal 
subunit 
Ribosome 
protection; efflux 
Erythromycin  Macrolides  Bind 50S ribosomal 
subunit 
Methylation or 
mutation of 23S 
rRNA; efflux 
Clindamycin  Lincosamides  Bind 50S ribosomal 
subunit 
Methylation or 
mutation of 23S 
rRNA; efflux 
Dalfopristin, 
quinupristin 
Streptogramins  Bind 50S ribosomal 
subunit 
Methylation or 
mutation of 23S 
rRNA; efflux 
Chloramphenicol  Phenicols  Bind 50S ribosomal 
subunit 
Chloramphenicol 
acetyltransferases 
Trimethoprim 
/sulfonamide 
Trimethoprim 
/sulfonamides 
Inhibit 
tetrahydrofolate 
pathway 
Mutations in the 
target enzymes   16 
medicine accounted for around 50% of global consumption of antibiotics, 
of which the majority were used for prophylaxis and growth promotion 
(Wise et al., 1998). Since then, the European Union has banned the use of 
antibiotics  for  the  latter  purpose  (European  Parliament  and  Council 
Regulation EC 1831/2003), but in the US and many developing countries 
antibiotics are still used as growth promoters. 
2.2  Antibiotic targets 
Antibiotics are antibacterial compounds that interfere with some structure 
or process that is essential to bacterial growth or survival, although in most 
cases  harmless  to  the  eukaryotic  host  harbouring  the  infecting  bacteria. 
Antibiotics  have  three  main  bacterial  targets:  (i)  cell-wall  synthesis  (e.g. 
betalactams,  glycopeptides);  (ii)  protein  synthesis  (e.g.  macrolides, 
tetracyclines and aminoglycosides); and (iii) DNA replication and repair (e.g. 
fluoroquinolones) (Walsh, 2000). Because lactobacilli are mainly associated 
with  resistance  to  macrolides  and  tetracyclines,  the  mode  of  action  and 
resistance  mechanisms  of  these  drugs  are  described  in  detail  below. 
Antibiotics  relevant  for  susceptibility  testing  of  LAB  are  summarised  in 
Table 1. 
2.3  The ribosome as antibiotic target 
Many chemically diverse antibiotics act by binding to the bacterial ribosome 
and thereby interfering with the synthesis of new proteins. High resolution 
atomic structures of the ribosome obtained by X-ray crystallography have 
recently revealed how some of these antibiotics target the ribosome (Fig. 
2A),  as  reviewed  by  Poehlsgaard  &  Douthwaite  (2005).  Most  of  the 
antibiotics  bind  reversibly  to  the  ribosome  and  are  bacteriostatic  at 
therapeutic concentrations. 
Ribosomes translate the genetic code via messenger RNA (mRNA) to 
assemble  amino  acids  into  proteins.  The  bacterial  ribosome  (Fig. 2B)  is 
made up of a small subunit (30S) and a large subunit (50S), both of which 
consist of a number of ribosomal proteins (r-proteins) and ribosomal RNAs 
(rRNAs), including 16S rRNA in 30S and 23S rRNA and 5S rRNA in 
50S.  The  30S  subunit  contains  the  A (aminoacyl)  site,  where  the 
aminoacylated transfer RNA (tRNA) attaches and in which is located the 
decoding  site, where each codon of the mRNA chain interacts with an 
aminoacylated tRNA anticodon. The 50S subunit contains the catalytic site, 
i.e. the peptidyl-transferase centre responsible for peptide bond formation,   17 
as well as the tunnel through which the newly synthesised peptide chain is 
channelled before leaving the ribosome (Fig. 2B). 
 
 
 
Figure 2. Structure of the small (30S) and large (50S) ribosomal subunits of bacteria with the 
ribosomal  binding  sites  of  some  antibiotics  inhibiting  protein  synthesis.  A=aminoacyl, 
P=peptidyl-transferase  centre,  and  E=exit  (A).  The  associated  subunits  (70S)  and  the 
interaction with mRNA and tRNA (B). Reproduced with the permission of the publisher 
(modified from Poehlsgaard & Douthwaite, 2005). 
2.3.1  Macrolides 
Macrolides  are  active  against  Gram-positive  bacteria  and  many  Gram-
negative  potential  pathogens  such  as  Campylobacter,  Legionella,  Chlamydia, 
Helicobacter  and  Mycoplasma.  Within  Swedish  veterinary  medicine, 
macrolides  are  especially  used  for  therapeutic  group  treatment  of  pigs 
(SVARM,  2007).  This  family  of  antibiotics  has  also  been  used  non-
clinically, as growth promoters in food-producing animals.    
Macrolides consist of a macrocyclic lactone ring of between 14 atoms 
(e.g. erythromycin, see Fig. 3A) and 16 atoms (e.g. tylosin) with different 
substituents.  Erythromycin  and  tylosin  are  naturally  occurring  antibiotics   18 
synthesised  by  actinomycete  bacteria,  whereas  newer  macrolides  such  as 
azithromycin  and  clarithromycin  are  semi-synthetic  compounds  with 
substitutions on the lactone ring resulting in fewer side effects and better 
pharmacological  properties.  Ketolides,  e.g.  telithromycin,  are  the  latest 
generation of derivatives with activity against some erythromycin resistant 
streptococci and staphylococci (Schulin et al., 1998; Malathum et al., 1999). 
 All macrolides target the 23S rRNA nucleotide A2058 within the 50S 
subunit  tunnel,  thereby  blocking  peptide  chain  elongation.  Lincosamides 
(e.g.  lincomycin  and  clindamycin)  and  streptogramin B  compounds  (e.g. 
quinupristin)  differ  chemically  from  macrolides,  but  also  interact  with 
nucleotides of the 23S rRNA, including A2058.  Crystallographic data on 
the  superposition  of  these  so-called  MLSB  antibiotics  in  the  ribosomal 
tunnel show that the structures clearly overlap (reviewed by Poehlsgaard & 
Douthwaite, 2005). 
 
 
Figure 3. Chemical structure of erythromycin (A) and tetracycline (B). 
2.3.2  Tetracyclines 
Tetracyclines  are  broad-spectrum  antibiotics,  with  activity  against  Gram-
positive  and  Gram-negative  bacteria,  Chlamydia  spp.,  Mycoplasma  spp., 
Rickettsiae  spp.  and  some  protozoa  (summarised  by  Roberts,  2003b). 
Tetracyclines are the most commonly prescribed antibiotics within Swedish 
human medicine after betalactams (Swedres, 2007) and are also widely used 
in veterinary medicine, especially for therapeutic group treatment of pigs 
(SVARM, 2007). Furthermore, tetracyclines have been used in horticulture 
(McManus et al., 2002), and are still used as growth promoters in some 
countries, including the United States.   19 
Tetracyclines consist of four linear fused cyclic six-membered rings with 
different substituents attached. Tetracycline (Fig. 3B), chlortetracycline and 
oxytetracyline are produced by Streptomyces spp., whereas newer derivatives 
such as doxycycline and minocycline are semi-synthetic compounds. The 
third and latest generation of tetracyclines is glycylcyclines, e.g. tigecyclin 
(former GAR-936), which has a bulky side chain designed to overcome 
resistance in some bacteria (Petersen et al., 1999). 
Uptake of tetracyclines into the bacterial cytoplasm favours the chelation 
of  tetracycline  with  magnesium  ions  (Chopra  &  Roberts,  2001).  These 
metal-drug  complexes  target  the  A  site  of  the  30S  bacterial  ribosomal 
subunit, causing conformational changes and thereby physically preventing 
the  binding  of  aminoacylated  tRNA  to  the  ribosome.  Tetracycline 
primarily interacts with the H34 region of the 16S rRNA at the A-site, 
which is involved in the binding of aminoacylated tRNA. This was verified 
by crystallographic structures of the 30S ribosomal subunit, complexed with 
tetracycline (Brodersen et al., 2000; Pioletti et al., 2001). The functional 
relevance of the five additional binding sites found is currently not clear. 
The  crystallographic  studies  in  combination  with  a  recent  report  on 
simulation of molecular dynamics (Aleksandrov & Simonson, 2008) suggest 
that the ‘upper’ part of the tetracycline molecule confers receptor binding 
specificity, whereas the ‘lower’ part controls magnesium binding.  
2.4  Resistance mechanisms 
Bacteria  utilise  four  major  strategies  to  become  resistant  to  antibiotics 
(Fig. 4): Decreased intracellular antibiotic concentration by altering cell wall 
permeability (A) or by efflux (B); enzymatic inactivation of the antibiotic 
(C); and modification of the antibiotic target (D). 
 
 
 
 
Figure  4.  Major  mechanisms  of  resistance  to 
antibiotics in a bacterial cell. 
enzymatic
B A
drug
D C  20 
2.4.1  Macrolide resistance 
The most common macrolide resistance mechanism in both Gram-positive 
and Gram-negative bacteria is target site modification caused by methylation 
or mutations. There are currently 33 described erm genes, encoding methyl 
transferases,  which  specifically  methylate  nucleotide  A2058  in  the  23S 
rRNA  of  the  50S  ribosomal  subunit  (Roberts,  2008).  Addition  of  one 
methyl  group  by  e.g.  erm(N)  confers  high  resistance  to  lincosamides, 
whereas  addition  of  two  methyl  groups  by  e.g.  erm(E)  confers  high 
resistance  to  all  MLSB  antibiotics,  including  telithromycin  (Liu  & 
Douthwaite, 2002). Erm genes are often linked via mobile genetic elements 
to other resistance genes, especially genes conferring tetracycline resistance 
(Roberts et al., 1999).    
Macrolide and/or MLSB resistance can also be caused by point mutations 
at A2058 or at adjacent nucleotides in the 23S rRNA and in the ribosomal 
proteins.  Details  of  various  mutations  found  in  Streptococcus  pneumoniae, 
Streptococcus  pyogenes  and  Haemophilus  influenzae  have  been  reported  by 
Franceschi  et  al.  (2004).  Resistance  caused  by  chromosomal  mutations 
generally presents a low risk of horizontal gene transfer, see below. 
Another  major  resistance  mechanism  is  through  efflux  pumps,  which 
transport macrolides out of the cell, thereby reducing the intracellular drug 
concentration. So far, there are 14 described genes encoding these proteins. 
Efflux  pumps  confer  diverse  levels  of  resistance  to  the  different  MLSB 
antibiotics (reviewed by Roberts et al., 1999; Roberts, 2008). The mef(A) 
gene,  encoding  specific  macrolide  efflux, has been found in a variety of 
Gram-positive bacteria, including S. pyogenes, where it was first described 
(Clancy  et  al.,  1996).  Roberts  and  co-workers  (1999)  standardised  the 
nomenclature for genes conferring macrolide and MLSB resistance. 
2.4.2  Tetracycline resistance 
Tetracycline resistance is now so widespread among bacteria that the utility 
of the tetracycline family has been considerably diminished. There are two 
ribosome-related mechanisms of tetracycline resistance in bacteria, both of 
which are linked to the primary binding site of the drug on the ribosome. 
This resistance is caused by ribosomal protection proteins (RPPs; Chopra & 
Roberts,  2001)  or,  more  rarely,  by  mutations at nucleotide 1058 of the 
16S rRNA (Ross et al., 1998). 
The  nomenclature  and  characterisation  of  38  tet/otr  genes  conferring 
/oxy/tetracycline resistance have previously been reviewed by Roberts et al. 
(2005). A 42nd tet gene was recently found (Brown et al., 2008), reflecting 
the ongoing increase in knowledge in the field. Eleven of these genes (e.g.   21 
tet(M),  tet(O)  and  tet(W))  encode  RPPs,  which  are  cytoplasmic  proteins 
with some sequence homology to elongation factors EF-Tu and EF-G. The 
RPPs are thought to interact with the H34 protein of the 16S rRNA at the 
A site, causing allosteric disruption of the primary binding site and thereby 
releasing  tetracycline  from  the  ribosome  (Connell  et  al.,  2003).  Most  of 
these  genes  have  been  found  in  both  Gram-negative  and  Gram-positive 
bacteria. 
Resistance  to  tetracycline  is  also  commonly  associated  with  efflux 
proteins. There are 26 tet efflux genes described so far, all of which confer 
resistance to tetracycline and doxycycline. Two of these genes, tet(K) and 
tet(L), are primarily found in Gram-positive bacteria. Efflux genes and genes 
encoding  RPPs  are  both  commonly  associated  with  mobile  genetic 
elements (Roberts, 2005).  
2.5  Transfer of resistance genes 
Antibiotic resistance traits are passed to daughter cells during replication of a 
bacterial strain (clone), so-called vertical or clonal dissemination. Horizontal 
transmission can provide a bacterial host of a different strain, species or even 
genus  with  genetic  information  that  can  be  transiently  needed,  such  as 
antibiotic resistance genes (Courvalin, 2006). Antibiotic exposure favours 
bacteria  that have acquired resistance determinants at the expense of the 
susceptible population. Subsequently, wild-type bacteria stop proliferating 
or die, enabling the resistant bacteria to increase in abundance. 
2.5.1  Horizontal gene transfer   
There  are  three  known  mechanisms  for  horizontal  transfer  of  resistance 
genes:  conjugation,  transformation  and  transduction.  Conjugation  is 
believed  to  be  the  most  important  mode  of  transfer  within  the 
gastrointestinal  microbiota  (reviewed  by  Licht  &  Wilcks,  2006).  By  this 
mechanism mobile genetic elements such as plasmids and transposons are 
transferred from one live bacterium to another through a protein tunnel 
that temporarily physically connects the bacteria. In Gram-negative bacteria, 
cell  to  cell  contact  is  achieved  by  the  formation  of  sex  pili,  whereas  in 
Gram-positive bacteria it is achieved through uncharacterised cell surface 
structures (Grohmann et al., 2003). 
Both plasmid-encoded and chromosome-located resistance genes can be 
transferred  via  conjugation.  Conjugative  plasmids  are  larger  than 
approximately 15 kb and are self-transmissible due to the presence of the 
origin  of  transfer  (oriT)  gene  and  transfer  (tra)  genes.  Unlike  plasmids,   22 
conjugative transposons are chromosomal elements that cannot replicate by 
themselves, but can move within the genome, e.g. from plasmid to plasmid 
or from chromosome to plasmid and vice versa (Salyers et al., 1995). Smaller, 
non-conjugative plasmids that carry mobilisation (mob) genes and the oriT 
sequence can be mobilised by taking advantage of the transfer machinery 
provided by conjugative elements (Francia et al., 2004). Studies on the in 
vivo conjugative transfer of resistance genes in the gastrointestinal microbiota 
of various animals have recently been reviewed by Licht and Wilcks (2006). 
Horizontal gene transfer can also occur by transformation, where DNA 
released from one bacterium is taken up by a competent bacterium, and by 
transduction, where DNA is transferred from one bacterium to another via 
bacteriophages (Licht & Wilcks, 2006). In both cases, the DNA generally 
must incorporate into the recipient genome by homologous recombination 
(Frost et al., 2005; Thomas & Nielsen, 2005). This implies narrow-host-
range gene transfer, which is in contrast to the much broader host range of 
e.g.  conjugative  transposons  (Salyers  et  al.,  1995).  However,  non-
homologous  recombination  is  possible  during  both  transformation  and 
transduction, e.g. if plasmid DNA is acquired (Frost et al., 2005; Thomas & 
Nielsen,  2005).  The  frequency  of  gene  transfer  depends  on  the  genetic 
material  to  be  transferred,  the  transfer  mechanism,  the  concentrations  of 
donor  and  recipient  strains  and  the  contacts  between  these,  and  the 
selection pressure (Donohue et al., 1998). 
2.6  Intrinsic and acquired resistance 
Bacterial  resistance  to  antibiotics  can  either  be  intrinsic  or  acquired 
(Courvalin, 2006). Intrinsic resistance is an inherent trait of bacteria and can 
be due to reduced permeability of certain antibiotics across the cell wall, 
absence  of  the  antibiotic  target  or  the  presence  of  low  affinity  targets. 
Glycopeptide resistance of heterofermentative lactobacilli is an example of 
intrinsic  resistance  and  is  caused  by  peptidoglycan dipeptides terminating 
with  D-lactate  instead  of  D-alanine,  the  cell  wall  target  precursor  for 
glycopeptide  activity  (Billot-Klein  et  al.,  1994;  Klein  et  al.,  2000).  In 
contrast,  a  bacterial  strain  can  acquire  resistance  either  by  mutation  in 
indigenous  genes  or  by  the  uptake  of  exogenous  resistance  genes  by 
horizontal transfer from other bacteria. By their nature, intrinsic resistance 
and resistance due to chromosomal mutation pose a low or even negligible 
risk for horizontal spread. Added resistance genes, especially those carried by 
mobile genetic elements, may be more easily transferred between bacteria.   23 
2.6.1  Microbiological breakpoints 
Bacteria  not  responding  even  to  maximum  doses  of  a  given  antibiotic 
during an infection are defined as clinically resistant. Clinical  breakpoints, 
based  on  pharmacokinetic, clinical and microbiological data, are used by 
clinicians  to  advise  on  antibiotic  therapy  in  patients  (EUCAST,  2000). 
Bacteria  that  have  acquired  resistance  mechanisms  can  grow  at  a  higher 
antibiotic concentration than the more susceptible wild-type population and 
are  defined  as  microbiologically  resistant.  Consequently,  the  resistant 
bacteria exhibit a higher MIC, i.e. the lowest concentration of an antibiotic 
that inhibits bacterial growth. 
Microbiological breakpoints, referred to as epidemiological cut-off values 
by  the  European  Committee  for  Antimicrobial  Susceptibility  Testing 
(EUCAST), are used for distinguishing between strains with and without 
acquired resistance genes (White et al., 2001). This categorisation is specific 
for each species and antibiotic and is based on the distribution of antibiotic 
MICs for a representative number of bacterial strains; 300-600 according to 
White et al. (2001). Theoretically, a uniform MIC distribution in the lower 
antibiotic  concentration  range  indicates  that  all  strains  are  susceptible;  a 
uniform  distribution  with  a  high  MIC  for  all  strains  may  be  due  to  an 
intrinsic trait; and a bimodal MIC distribution indicates that the strains with 
a  high,  atypical  MIC  may  have  acquired  resistance.  However,  this 
differentiation is not always clear-cut in practice. 
2.6.2    Phenotypic methods 
Several methods have been used for phenotypic assessment of the antibiotic 
susceptibility of bacteria. Agar dilution and broth microdilution (right figure 
on front page) are dilution methods in which bacterial strains are tested for 
their ability to produce visible growth on a series of agar plates or in broth 
in  microtitre  wells  containing  serial  two-fold  dilutions  of  different 
antibiotics.  The  MIC  is  read  as  the  first  plate  or  well  without  growth. 
Dilution  methods  are  the  reference  methods  for  antibiotic  susceptibility 
testing in aerobic (CLSI, 2008) and anaerobic bacteria (CLSI, 2007). 
The  Etest  (left  figure  on  front  page)  is  a  commercial  product  and 
comprises a preformed, predefined gradient of antibiotic concentrations on 
a plastic strip. When the strip is applied to an inoculated agar plate, the 
gradient is transferred to the agar and established along the strip. The MIC 
is read where the edge of the elliptic inhibition zone formed intersects the 
Etest strip. Another diffusion method is disc diffusion, which comprises a 
disc containing a specific antibiotic concentration. Radial diffusion of the 
antibiotic into the inoculated agar creates an inhibition zone, the diameter   24 
of which is subsequently measured. In contrast to the latter method, the 
Etest and both dilution methods give MICs, i.e. quantitative data on the 
bacterial strains tested.   
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3  Lactobacilli 
3.1  Occurrence and taxonomy 
Lactobacilli  are  fastidious  bacteria,  found  in  a  variety  of  nutrient-rich 
environments such as meat and dairy products, plant material, animal and 
human  mucosal  surfaces,  and  sewage  and  manure  (Hammes  &  Hertel, 
2006).    
The genus Lactobacillus is a heterogeneous group of LAB, exemplified by 
the genome G+C content ranging from 32 to 54% of the species included 
(Schleifer & Ludwig, 1995). Genetic characterisation has also revealed that 
the  former  classification  of  lactobacilli  into  obligately  homofermentative, 
facultatively  heterofermentative  and  obligately  heterofermentative 
(summarised  by  Hammes  &  Vogel,  1995)  is  only  partly  connected  to 
phylogeny. Sequencing of the 16S rRNA genes has been used to divide the 
more  than  one  hundred  currently  identified  Lactobacillus  spp.  into  seven 
(Hammes & Hertel, 2006) or 12 (Felis & Dellaglio, 2007)  phylogenetic 
groups.  However,  the  grouping  of  the  genus  may  be  subject  to  future 
changes  as  more  whole-genome  sequences  become  available  and  new 
species are continuously identified (Claesson et al., 2008). The phylogenetic 
diversity of lactobacilli is displayed in Fig. 5.  
3.1.1  Occurrence and taxonomy of L. reuteri and L. plantarum 
Lactobacillus reuteri is an obligate heterofermenter belonging to the L. reuteri 
phylogenetic  group,  whereas  L. plantarum  is a facultative heterofermenter 
belonging  to  the  L. plantarum  phylogenetic  group  (Hammes  &  Hertel, 
2006). These bacteria occur naturally in the gastrointestinal, vaginal and oral 
tracts of humans and other warm-blooded animals, and L. plantarum is also 
found naturally in plant material (Hammes & Hertel, 2006).   26 
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Figure 5. Evolutionary relationship between lactobacilli based on a neighbour-joining tree of 
16S rRNA gene sequences. Bootstrap values above 600 are indicated. Outgroups are shaded 
in  grey.  Scale  bars  indicate  0.1  nucleotide  substitutions  per  site.  Reproduced  with  the 
permission of the publisher (modified from Ventura et al., 2009). 
3.2  Industrial applications 
The two major applications of lactobacilli are as starter cultures of food and 
feed  and  as  probiotics.  In fermentations, lactobacilli are either present as 
natural contaminants, added as a component of a previous batch or added as 
a pure or mixed culture. The purpose is to affect flavour and texture and to 
improve the safety and shelf-life of the final product. Examples of fermented 
products inoculated with lactobacilli include meat products, dairy products, 
sourdough, vegetables and silage (Hammes & Hertel, 2006). 
  Probiotics are defined as ‘live organisms, which when administered in 
adequate  amounts,  confer  a  health  benefit  on  the  host’  (FAO/WHO, 
2001).  Species  of  Lactobacillus  and  Bifidobacterium  are  the  bacteria  most 
commonly used as probiotics (Saxelin et al., 2005). Specific human strains of   27 
e.g. L. casei, L. johnsonii, L. rhamnosus, L. plantarum and L. reuteri have been 
shown to be protective against a variety of gastrointestinal infections and 
allergic disorders (reviewed by Saxelin et al., 2005; Britton & Versalovic, 
2008).  However,  the  mechanisms  of  action  of  these  bacteria  are  just 
beginning to be understood. Putative probiotic mechanisms are related to 
production  of  antimicrobial  compounds,  interference  with  pathogens  in 
terms of competition for nutrients or mucosal attachment, enhancement of 
intestinal  barrier  function  and  immunomodulation  (Saxelin  et  al.,  2005; 
Britton & Versalovic, 2008). 
3.2.1  Industrial applications of L. reuteri and L. plantarum 
Lactobacillus plantarum is commonly used as an inoculant for fermented meat, 
milk and dairy products as well as for vegetables and silage (Hammes & 
Hertel, 2006). Both L. reuteri and L. plantarum are associated with lactic acid 
fermentations of sour dough (Vogel et al., 1994; Hufner et al., 2008) and 
selected strains are used as probiotics (Casas & Dobrogosz, 2000; Molin, 
2001). 
 Lactobacillus reuteri  (strain  ATCC 55730)  has  been  shown  in  several 
clinical  studies  to  improve  outcome  in  various  disorders  such  as  acute 
rotavirus diarrhoea (Shornikova et al., 1997), colic in babies (Savino et al., 
2007), IgE-associated allergy (Abrahamsson et al., 2007), infectious illness in 
nursery  infants  (Weizman  et  al.,  2005)  and  Helicobacter  pylori  infection 
(Francavilla et al., 2008). The underlying primary mechanisms conferring 
the antipathogenic properties of L. reuteri are currently not known (Britton 
&  Versalovic,  2008).  Bacteria  of  the  L. reuteri  species  produce  a  broad-
spectrum antimicrobial compound, reuterin (3-hydroxy-propionaldehyde), 
when using glycerol as an electron acceptor (Talarico et al., 1988). Reuterin 
could potentially be applied for decontamination and preservation of meat 
(El-Ziney et al., 1999), but whether this compound is partly responsible for 
the probiotic effects of L. reuteri remains to be proven. 
3.3  Safety aspects 
Lactobacilli have a long history of safe use as food and feed processing aids, 
and,  as  previously  mentioned,  certain  Lactobacillus  strains  confer  a  health 
benefit on humans and animals. Despite the ingestion of large numbers of 
lactobacilli  with  fermented  food  and  their  wide  distribution  in  high 
numbers in the human microbiota, very few adverse clinical effects have 
been  reported,  justifying  this  safety  status  (Hammes  &  Hertel,  2006). 
However,  lactobacilli  may  function  as  a  reservoir  of  antibiotic  resistance   28 
genes (Teuber et al., 1999) (see below), and some strains exhibit certain 
metabolic  activities  considered  disadvantageous  with  regard  to  consumer 
safety (reviewed by Bernardeau et al., 2006). Metabolites such as D-lactate 
and biogenic amines can be produced and accumulate in fermented dairy 
products. Platelet aggregation and bile salt deconjugase activities are other 
examples  of  lactobacilli  properties  of  concern  (Bernardeau  et  al.,  2006). 
However, there is currently insufficient evidence available to link some of 
these metabolic activities to significant safety risks (Connolly et al., 2005; 
Vankerckhoven et al., 2008). 
Lactobacilli have in rare cases caused infections such as bacteraemia and 
endocarditis (e.g. Salminen et al., 2004; Cannon et al., 2005). The incidence 
of lactobacilli-induced bacteraemia was less than 1% of the total number of 
bacteraemia cases reported each year in Sweden between 1998 and 2004 
(Sullivan  &  Nord,  2006).  Cannon  et  al.  (2005)  reviewed  241  cases  of 
Lactobacillus-associated  infection  reported  worldwide  between  1950  and 
2003. The majority of these infections occurred in immunocompromised or 
severely  ill  patients.  Lactobacillus  rhamnsous  and  L. casei  were  the  most 
frequently isolated species, followed by L. plantarum and L. acidophilus. In 
four of the cases, the infection was related to heavy dairy consumption and 
for one patient, with a liver abscess, the probiotic strain L. rhamnosus GG 
was reported as the causative agent (Rautio et al., 1999). The same strain, 
originally  isolated  from  the  human  intestine,  caused  11  (12%)  cases  of 
Lactobacillus  bacteraemia  reported  between  1990  and  2000  in  Finnish 
patients,  all  but  one  having  a  severe  underlying  illness  (Salminen  et  al., 
2004). However, there was no correlation between the increased probiotic 
use  of  L. rhamnosus GG  and  the  incidence  of  lactobacilli  bacteraemia  in 
Finland  during  1990-2000  (Salminen  et  al.,  2002).  In  most  cases  of 
Lactobacillus infection, the host's own microbiota is likely to be the source of 
infection (Vesterlund et al., 2007). One case of bacteraemia caused by an 
L. reuteri isolate has been reported (Vesterlund et al., 2007). 
3.3.1  Safety assessment of lactobacilli 
As  previously  mentioned,  legislation  exists  regarding  antibiotic  resistant 
LAB  used  for  feed  applications  (European  Parliament  and  Council 
Regulation EC 429/2008), but not for food and probiotic applications. Due 
to the wide use of lactobacilli as starter cultures and probiotics for humans 
and to the increasing application of novel strains, especially for probiotic 
purposes (Temmerman et al., 2003), there is a strong need for valid safety 
assessments prior to commercial use. At present, there are several unofficial 
guidelines, which vary in their recommendations, but which taken together   29 
suggest assessing properties related to systemic infections, harmful metabolic 
activity, excessive immune stimulation and transferability of resistance genes 
(Adams, 1999; Marteau, 2001; FAO/WHO, 2002). However, more recent 
guidelines consider transferable antibiotic resistance to be the major hazard 
concerning commercially used lactobacilli (EFSA, 2007; Bernardeau et al., 
2008;  Vankerckhoven  et  al.,  2008).  Currently,  these  guidelines  are  not 
mandatory because they have not been adopted by any authority and hence 
it  is  up  to  the  probiotic  or  starter  producer  to  decide  on  the  safety 
assessment procedure for a novel strain. 
Antibiotic resistance in lactobacilli has been heavily debated during the 
last decade. Lactobacilli intentionally added to the food chain should not 
carry  transferable  antibiotic  resistance  genes  according  to  EFSA  (2007). 
Thus, such traits are currently a ‘no go area’ in the development of new 
strains.  Alternatively,  curative  strategies  could  be  applied  to  health-
promoting  or  starter  lactobacilli  strains  to  remove  plasmids  carrying 
unwanted  antibiotic  resistance  genes  (Huys  et  al.,  2006;  Rosander  et al., 
2008).  One  such  example  is  the  commercial  probiotic  L. reuteri  strain 
DSM 17938,  which  was  derived  from  L. reuteri  ATCC 55730  by  the 
removal  of  two  resistance  plasmids  (Fig. 8)  without  losing  any  probiotic 
characteristics (Rosander et al., 2008). 
3.4  Antibiotic resistance in lactobacilli 
Until  1999,  there  were  only  a  few  systematic  studies  assessing  acquired 
antibiotic  resistance  in  LAB,  including  lactobacilli.  Teuber  et  al.  (1999) 
therefore suggested that the potential of commensal bacteria to transfer their 
antibiotic resistance genes from food to the indigenous human microflora 
should be investigated. Since the initial publication of the regulation on the 
use of antibiotic resistant microorganisms as feed additives (EC, 2001) and 
the  report  by  Danielsen  &  Wind  (2003)  opposing  the  microbiological 
breakpoints  defined  by  this regulation, antibiotic susceptibility profiles in 
terms  of  wild-type  MIC  distributions  have  been  reported  for  several 
individual Lactobacillus spp. (e.g. Klare et al., 2007; Danielsen et al., 2008; 
Huys et al., 2008; Papers II and III).  
Heterofermentative lactobacilli are, as previously mentioned, intrinsically 
resistant  to  glycopeptides  such  as  vancomycin,  whereas  most  obligate 
homofermentative  species  are  susceptible  (Danielsen  &  Wind,  2003). 
Lactobacilli  are  generally  susceptible  to  penicillins,  and  more  resistant  to 
cephalosporins  such  as  ceftriaxone,  a  third-generation  cephalosporin 
(Danielsen  &  Wind,  2003).  The  resistance  mechanism  is  not  fully   30 
elaborated,  but  cell  wall  impermeability  and  non-specific  multidrug 
transporters may be involved (Ammor et al., 2007). Lactobacilli seem to be 
intrinsically resistant to quinolones, e.g. ciprofloxacin and nalidixic acid, by 
a  currently  unknown  resistance  mechanism  (Hummel  et  al.,  2007). 
Resistance to other inhibitors of nucleic acid synthesis such as trimethoprim 
and sulphonamides has also been reported as an intrinsic feature (Katla et al., 
2001).  However,  this  was  probably  due  to  thymidine  in  the  growth 
medium, which is antagonistic to antibiotic activity (Danielsen et al., 2004). 
Lactobacilli  are  generally  susceptible  to  all  protein  synthesis  inhibitors 
except aminoglycosides. Intrinsic resistance to the latter group of antibiotics 
is  attributed  to  the  absence  of  cytochrome-mediated  electron  transport, 
enabling antibiotic uptake (Charteris et al., 2001). However, aacA-aphD as 
well as aadE and aphA3, encoding aminoglycoside modifying enzymes, have 
previously been found in L. acidophilus and L. salivarius strains isolated from 
animal faeces (Tenorio et al., 2001) and in L. curvatus from an unpasteurised 
milk  cheese  (Danielsen  et  al.,  2005),  respectively.  Acquired  resistance 
determinants for tetracyclines, chloramphenicol and MLSB antibiotics have 
been found in lactobacilli isolates from a variety of habitats. Identical genes 
mediating  resistance  to  these  antibiotics  have  also  been  found  in  e.g. 
streptococci  and  enterococci,  showing  that  there  is  no  barrier  between 
lactobacilli  and  pathogenic  species  (Teuber  et  al.,  1999).  Tetracycline 
resistance genes tet(K, L, M, O, Q, S, W, 36) have been reported in various 
Lactobacillus species (Chopra & Roberts, 2001; Roberts, 2005; Ammor et al., 
2007). The overall most frequently found tet gene, tet(M), has previously 
been identified in strains of L. plantarum, L. alimentarius, L. curvatus, L. casei, 
L. acidophilus, L. gasseri, L. crispatus and L. sakei (Gevers et al., 2003a; Klare 
et al., 2007), and more recently also in L. reuteri (van Hoek et al., 2008). 
Ammor et al. (2008) recently identified a plasmid-encoded tet(L) gene and a 
chromosome-located transposon-associated tet(M) gene in a single L. sakei 
strain. 
MLSB resistance in lactobacilli is frequently associated with the presence 
of erm(B) and in a few cases erm(C), erm(G) and erm(T) (Roberts, 2003a; 
Ammor et al., 2007). Besides erm genes, acquired resistance to lincosamides 
has been caused by lnu(A) in the probiotic strain L. reuteri ATCC 55730 
(Kastner et al., 2006) and to streptogramins A by vat(E-1) in an L. fermentum 
strain from unpasteurised milk (Gfeller et al., 2003), respectively. Macrolide 
resistance in lactobacilli caused by a point mutation at A2058 in the 23S 
rRNA has so far only been found in an L. rhamnosus strain of human origin 
(Florez  et  al.,  2007).  Plasmid-encoded  genes  mediating  chloramphenicol 
resistance (cat) have been identified in L. plantarum from pork (Ahn et al.,   31 
1992), L. reuteri from chicken (Lin et al., 1996) and in three L. johnsonii 
from  calf,  pig  and  turkey  (van  Hoek  et  al.,  2008).  The  gene  of  the 
L. plantarum  strain  was  similar  to  a  streptococcal  cat  gene  and  could  be 
transferred by conjugation with a helper plasmid to a Carnobacterium strain 
(Ahn et al., 1992). Transferable multiresistance in lactobacilli is rare so far, 
with the exception of erm-vat-tet resistance in an L. fermentum strain (Gfeller 
et  al.,  2003)  and  erm-vat-tet-aad-aph-sat  resistance  in  an  L. curvatus  strain 
(Danielsen et al., 2005), both isolated from cheeses made from unpasteurised 
milk. 
Lactobacilli, like other bacteria, have probably acquired most antibiotic 
resistance  genes  by  conjugation  (Ammor  et  al.,  2007),  but  transfer  of 
resistance  genes  by  transduction  has  also  been  reported  (Morelli  et  al., 
2004).  Natural  transformation  has  not  been  described  in  lactobacilli 
(Ammor et al., 2007), although genes involved in uptake of free DNA have 
been found in e.g. L. reuteri (Båth et al., 2005; H. Jonsson, pers. comm. 
2009).  Several  mobilisable  plasmids  have  been  described,  e.g.  the 
tetracycline resistance plasmid pMD5057 of L. plantarum 5057 (Danielsen, 
2002)  and  the  erythromycin  and  streptogramin A  resistance  plasmid 
pLME300 of L. fermentum ROT1 (Gfeller et al., 2003). There are to date no 
reports  linking  conjugative  transposons  and  antibiotic  resistance  in 
lactobacilli (Ammor et al., 2007). 
In vitro and in vivo conjugal transfer of the introduced, broad-host-range 
plasmid  pAMβ1  has  previously  been  demonstrated  between  different 
lactobacilli  and  between  lactobacilli  and  enterococci,  lactococci  or 
streptococci, respectively (Tannock, 1987; Morelli et al., 1988; McConnell 
et al., 1991; Vogel et al., 1992). In food, fermented sausages have been the 
site of observed transfer of pAMβ1 between L. curvatus strains  (Vogel et al., 
1992).  Interspecies  gene  transfer  to  E. faecalis  of  mobilisable  erm  or 
tet-containing  plasmids  from  food-related  L. plantarum  has  been 
demonstrated in vitro (Gevers et al., 2003b; Feld et al., 2008) and in the 
intestinal tract of gnotobiotic rats (Jacobsen et al., 2007; Feld et al., 2008). 
Transfer to E. faecalis of an erm gene in an L. reuteri strain from pig has also 
recently been demonstrated in vitro (Ouoba et al., 2008). However, no erm 
gene transfer from L. plantarum has been observed in vivo in the presence of 
a surrounding microbiota, either with or without selection pressure (Feld et 
al.,  2008). Mater et al. (2008) recently showed that probiotic lactobacilli 
may also acquire antibiotic resistance in vivo. However, the extent to which 
lactobacilli contribute to dissemination of antibiotic resistance genes in the 
human  gut  is  not  clear  and  this  issue  thus  needs  further  attention  with 
regard to consumer safety.   32 
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4  Results and discussion 
In the following chapter, the main findings of the papers included in this 
thesis are summarised and discussed. 
4.1  Antibiotic susceptibility testing (II II II II and III  III  III  III) 
Distributions of antibiotic MICs for a representative set of strains within a 
species are needed when using a phenotypic method to assess the presence 
of acquired resistance genes (White et al., 2001). Antibiotic susceptibility 
profiles  based  on  wild-type  MIC  distributions  were  determined  for  56 
L. reuteri  strains  of  animal  and  human  origin  (Paper  II),  56  L. fermentum 
strains of dairy origin (not discussed further here; Paper II), and for 121 
L. plantarum  strains of dairy and vegetable origin (Paper III). During the 
compilation of L. reuteri and L. plantarum strains for this thesis, efforts were 
made to obtain a wide distribution in terms of source, year of isolation, 
geographical  origin  and  clonal  diversity.  The  source  and  spatial  and 
temporal origin of the L. reuteri strains are shown in Fig. 6. 
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Figure 6. Source (A), geographical origin (B) and year of isolation (C) of the 56 L. reuteri 
strains.   34 
Species confirmation was conducted by sequence analysis of the 16S rRNA 
gene and subtyping by rep-PCR genomic fingerprinting using the primer 
(GTG)5,  a  method  that  has  previously  been  successfully  applied  in 
lactobacilli  for  this  purpose  (Gevers  et  al.,  2001).  Because  L. plantarum, 
L. pentosus  and  L. paraplantarum are genotypically closely related and thus 
have  nearly  identical  16S  rRNA  gene  sequences  (Quere  et  al.,  1997), 
identification of L. plantarum strains was also confirmed by a species-specific 
multiplex PCR (Torriani et al., 2001). 
The  antibiotics  tested  throughout  the  studies  were  ampicillin, 
tetracycline, erythromycin, clindamycin, streptomycin and gentamicin. The 
susceptibility  of  eight  additional  antibiotics  for  which  EFSA  (2005)  also 
defined microbiological breakpoints was tested for L. reuteri (Table 2). 
4.1.1  Evaluation of a broth microdilution method (I I I I) 
Besides  testing  a  variety  of  strains  belonging  to  the  same  species, 
standardised  and  reliable  testing  procedures  are  needed  for  accurate 
recognition  of  strains  harbouring  acquired  resistance  genes  (White  et  al., 
2001). There is currently no standard method for antibiotic susceptibility 
testing of Lactobacillus spp. At present, the Clinical and Laboratory Standards 
Institute (CLSI) recommends broth microdilution for susceptibility testing 
of  clinical  Lactobacillus  isolates  that  cause  endocarditis  and  bacteraemia 
(Jorgensen & Hindler, 2007). However, the suggested testing medium is 
blood-supplemented Müeller-Hinton, which does not support the growth 
of all Lactobacillus species (Huys et al., 2002; Klare et al., 2005). In a recent 
report, no growth was obtained for 3 out of 20 food-related lactobacilli 
isolates tested as recommended by the CLSI guideline (Ge et al., 2007). 
Consequently, a variety of methods have been applied for lactobacilli, such 
as  broth  microdilution  (Flórez  et  al.,  2005;  D'Aimmo  et  al.,  2007),  agar 
dilution  (Chou  et  al.,  2004;  Korhonen  et  al.,  2007),  Etest  (Danielsen  & 
Wind, 2003; Hummel et al., 2007) and disc diffusion (Temmerman et al., 
2003; Kastner et al., 2006). In many of these studies, the testing medium 
used was MRS, which can exert an antagonistic effect on certain antibiotics 
(Huys et al., 2002; Klare et al., 2005). LAB susceptibility test medium (LSM; 
isosensitest  90%  (v/v)  and  MRS  10%  (v/v),  pH  6.7)  was  developed  by 
Klare and co-workers (2005) to overcome the disadvantages of previously 
used  media.  Other  factors  that  may  limit  the  reproducibility  and 
comparability of MIC data between different laboratories are inoculum size, 
incubation  time,  incubation  temperature  and  composition  of  the 
atmosphere (White et al., 2001). This led to the study described in Paper I,   35 
in  which  the  effects  of  inoculum  size  and  incubation  time  on  broth 
microdilution susceptibility testing of some LAB were evaluated. 
MICs  for  29  LAB  reference  strains  (27  Lactobacillus,  1  Streptococcus 
thermophilus and 1 Lactococcus lactis) and six clinical Lactobacillus isolates against 
six antibiotics were determined using a commercial microdilution panel at 
inoculum densities ranging from 3 × × × × 10
4 to 3 × × × × 10
7 CFU/mL and at 24 and 
48 h of incubation. The Lactobacillus reference strains encompassed different 
phylogenetic groups and sugar fermentation pathways (Table 1 in Paper I). 
Increased  inoculum  size  and  extended  incubation  time  both  resulted  in 
elevated  antibiotic  MICs  for  all  LAB  species  tested,  underlining  the 
importance  of  controlled  and  standardised  conditions  for  susceptibility 
testing of LAB. An inoculum size of 3 × × × × 10
5 CFU/mL and an incubation 
time of 48 h were recommended to assess the antibiotic susceptibility of 
LAB using broth microdilution and LSM. 
 Standard  operating  procedures  for  antibiotic  susceptibility  testing  of 
lactobacilli using broth microdilution and an Etest method were elaborated 
within the ACE-ART project as a first step toward standardised methods. 
These were based on intra- and interlaboratory tests performed within the 
ACE-ART project (G. Huys, pers. comm. 2009), the use of LSM and the 
results obtained in Paper I for broth microdilution. The MIC distributions 
obtained in Papers II and III were subsequently determined according to 
these  protocols.  Currently,  the  broth  microdilution  protocol  is  under 
evaluation  at  the  International  Dairy  Federation  (IDF)  for  use  as  an 
international ISO/IDF standard method (Danielsen & Seifert, 2008). 
4.1.2  Comparison of Etest and broth microdilution MICs (II II II II and III III III III) 
Information  concerning  the  comparability  of  different  methods  for 
antibiotic  susceptibility  testing  of  lactobacilli  is  limited.  All  56  L. reuteri 
strains  and  72  of  the  L. plantarum  strains  were  therefore  tested  for  their 
responses to six antibiotics with both the Etest and the broth microdilution 
assay. The need for MIC methods in combination with previous experience 
of these methods in the ACE-ART project were the reasons for using them 
in this thesis. 
For L. reuteri, 86% of the 258 strain-antibiotic combinations resulting in 
MICs within the test range with both methods were within the accuracy 
limit of MIC determination tests, i.e. ± one log2 dilution step (CLSI, 2005; 
Table  2  in  Paper  II).  The  MIC  agreement  was  less  pronounced  for 
ampicillin and clindamycin. Similar results were obtained for L. plantarum 
for 329 MICs within the test range (data not shown). The correlation of 
MICs  determined  by  Etest  and  broth  microdilution  on/in  LSM  has   36 
previously  been  reported  for  LAB  such  as  L. paraplantarum  (Huys  et  al., 
2008). Only 56% of the MIC data were within the accuracy limit, with 
generally two log2 dilution steps higher MICs obtained by Etest than by 
broth  microdilution  for  the  aminoglycosides  tested.  However,  for 
Streptococcus thermophilus (Tosi et al., 2007) and members of the L. acidophilus 
group (Mayrhofer et al., 2008), the percentage of MICs falling within one 
log2 dilution step was approximately 80%, with the highest discrepancies 
obtained for clindamycin and tetracycline and, as in Papers II and III, with 
generally  higher  MICs  obtained  by  broth  microdilution  than  by  Etest. 
Taken together, MICs obtained by the two methods are comparable and 
either  method  could  thus  be  used  to  assess  the  presence  of  acquired 
antibiotic resistance genes. 
In  my  opinion,  broth  microdilution  provides  a  simple  method  to 
determine MICs for a large number of strains and antibiotics, whereas the 
Etest could be more suitable for testing single strains. However, resistant 
and susceptible strains were generally more clearly separated by Etest in the 
present investigation due to the wider and more precise (MICs between the 
log2 dilution steps) antibiotic concentration range of the Etest. However, 
the Etest in particular needs trained eyes to determine correct MICs. 
4.2  Antibiotic resistance in L. reuteri (II II II II and I I I IV V V V) 
The susceptibility of 56 L. reuteri strains to 14 antibiotics was assessed by 
Etest  and/or  broth  microdilution  (Paper  II).  Strains  exhibiting  atypical 
MICs  were  subsequently  screened  by  real-time  PCR  and/or  a  DNA 
microarray  assay  for  the  presence  of  known  resistance  genes  (Paper  IV). 
Antibiotic  susceptibility  ranges  and  identified  resistance  genes  are 
summarised in Table 2. The distribution of MICs was uniform for most 
antibiotics,  with  MICs  in  the  lower  range  for  linezolid,  gentamicin  and 
netilmycin and in the upper range for amikacin and streptomycin. All MICs 
for  kanamycin,  vancomycin  and  trimethoprim  were  high,  with  strains 
exhibiting  MICs  above  the  maximum  concentration  tested.  Bimodal 
distributions  of  MICs  were  obtained  for  ampicillin,  chloramphenicol, 
tetracycline, erythromycin, clindamycin and dalfopristin-quinupristin. 
Intrinsic  resistance  to  vancomycin  and  aminoglycosides  such  as 
streptomycin  and  kanamycin  has  been  reported  as  a  general  feature  for 
lactobacilli (Danielsen & Wind, 2003), and stems from the absence of the 
peptidoglycan  D-alanine  target  precursor  and  the  lack  of  a  cytochrome-
mediated transport system required for aminoglycoside uptake, respectively. 
However, the reduced susceptibility to trimethoprim reported here and by   37 
others (Charteris et al., 1998; Klein et al., 2000; Klare et al., 2007) is not 
caused by an intrinsic trait, but is probably due to thymidine in the growth 
medium, which is antagonistic to antibiotic activity (Danielsen et al., 2004). 
Table  2.  Antibiotic  susceptibility  ranges  in  terms  of  distribution  of  typical  and  atypical  MICs  for 
L. reuteri obtained by Etest and identified resistance genes. 
Antibiotic  Wild-type  
MIC range 
(µg/mL) (n) 
Atypical   
MIC range 
(µg/mL) (n) 
Identified resistance genes (n) 
Ampicillin   ≤0.12-2 (42)         8-32 (14)  Mutational pbp’s
a 
Vancomycin       >256 (49)     
Amikacin        4-64 (49)     
Gentamicin       0.5-4 (56)     
Kanamycin  16->256 (49)     
Netilmycin     0.25-4 (49)     
Streptomycin        8-64 (56)     
Erythromycin     0.25-2 (50)          >256 (6)  erm(B) (4), erm(C) (1), erm(T) (1) 
Clindamycin   ≤0.12-2 (50)          >256 (6)  erm(B) (4), erm(C) (1), erm(T) (1) 
Dalfopristin-quinup.
b     0.25-1 (46)           8-16 (3)  erm(B) (3) 
Tetracycline        4-32 (28)  128->256 (28)  tet(W) (24) 
Chloramphenicol         2-4 (48)             128 (1)  cat(TC) (1) 
Linezolid         1-4 (49)     
Trimethoprim      >256 (49)     
a(Rosander et al., 2008) 
bDalfopristin-quinupristin 
 
For ampicillin, atypical MICs of 8-32 µg/ml were obtained for almost one- 
third of the strains. This is in contrast to the common opinion of lactobacilli 
being  susceptible  to  penicillins  in  general  (Danielsen  &  Wind,  2003; 
Hummel et al., 2007). The genetic mechanism conferring high ampicillin 
MICs in strains of L. reuteri has been subject to investigation (Rosander et 
al., 2008) since the publication of Paper II. Five genes encoding penicillin-
binding  proteins  (Pbp),  the  target  of  betalactam  antibiotics,  from  three 
susceptible strains (DSM 20015, DSM 20016, and ATCC 55148) and three 
less susceptible strains (ATCC 55730, ATCC 55149, and CF48-3A1) have 
been sequenced. Point mutations generating amino acid substitutions in the 
corresponding proteins Pbp1a, Pbp2a and/or Pbp2x have been found to be 
correlated with the atypical ampicillin MICs and are suggested to cause the 
resistance.  This  resembles  the  identified  cause  of  penicillin  resistance  in   38 
streptococci  (Hiramatsu  et  al.,  2004).  The  pbp  genes  are  located  on  the 
chromosome and regarded as non-transferable (Rosander et al., 2008). 
For chloramphenicol, the wild-type distribution ranging up to 4 µg/mL 
was in agreement with a previous susceptibility study of L. reuteri (Klare et 
al., 2007). Lactobacillus reuteri strain 5010, isolated from dog and exhibiting a 
30 times higher chloramphenicol MIC harbours a plasmid-located cat(TC) 
gene encoding a chloramphenicol acetyltransferase. However, the gene is 
not identical to the plasmid pTC82 encoded cat(TC) gene of L. reuteri G4 
from chicken (Lin et al., 1996), as demonstrated by the negative result using 
an additional set of primers designed by Cataloluk and co-workers (2004) 
and covering the whole cat(TC) gene (data not shown). Another L. reuteri 
strain,  ATCC PTA6127,  isolated  in  1994-95  from  a  Peruvian  dog  and 
displaying  a  similar  rep-PCR  fingerprint  but  with  MIC  4  µg/mL  for 
chloramphenicol,  was  negative  in  the  first  PCR  screening  to  the 
chloramphenicol resistance gene tested. Chloramphenicol is used for certain 
life-threatening  infections  such  as  typhoid  fever,  but  it  can  cause  fatal 
aplastic  anaemia  at  therapeutic  doses  in  humans,  limiting  its  use  within 
human  medicine.  However,  chloramphenicol  is  used  for  several  disease 
conditions in domestic animals (Schwarz et al., 2004), which could be a 
plausible  explanation  for  the  occurrence  of the  chloramphenicol  resistant 
L. reuteri strain isolated from dog. 
4.2.1  Tetracycline resistance in L. reuteri 
In total, 28 strains displayed MICs above 64 µg/mL for tetracycline with 
both Etest and broth microdilution. The wide range of high MICs obtained 
was in agreement with a previous study assessing antibiotic susceptibility of 
43 L. reuteri strains isolated from piglets (Korhonen et al., 2007). Based on 
the appearance of the tetracycline MIC distribution, it was first believed that 
the  L.  reuteri  strains  harboured  different  tetracycline  resistance  genes 
conferring diverse levels of susceptibility, as reviewed by Chopra & Roberts 
(2001). However, real-time PCR revealed the presence of tet(W) in 24 of 
the  28  L. reuteri  strains  with  atypical  MIC  for  tetracycline.  None  of  the 
other five tetracycline resistance genes tested (tet(K), tet(L), tet(M), tet(O), 
and  tet(S))  were  found  in  any  strain  including  the  four  tet(W)  negative 
strains Cow 10, ATCC 55148, MF2-3 and MF14-C. 
The  tet(W)  gene  is  commonly  found  in  human  and  animal  intestinal 
Gram-positive  bacteria,  such  as  various  species  of  Bifidobacterium, 
Butyrivibrio,  Mitsuokella  and  Fusobacterium  (Kazimierczak  et  al.,  2006;  van 
Hoek  et  al.,  2008).  Since  the  genotypic  data  of  the  ACE-ART  project 
became available (van Hoek et al., 2008), it is evident that tet(W) is also   39 
found  in  various  Lactobacillus  species  such  as  L. amylovorus,  L. brevis, 
L. crispatus, L. gallinarum, L. johnsonii, L. paracasei and L. reuteri. In Papers II 
and IV, we demonstrated that L. reuteri, displaying 40-42% G+C content 
(Hammes & Hertel, 2006), is frequently associated with tet(W), whereas the 
closely  related  species  L. fermentum,  displaying  52-54%  G+C content 
(Hammes & Hertel, 2006), is susceptible to tetracycline. Interestingly, this is 
in contrast to the proposed theory that tet(W), which has a much higher 
G+C  content  (53%)  than  other  ribosome-protection-type  tet  genes,  is 
generally associated with bacterial hosts with a similar G+C-content, such as 
bifidobacteria and Mitsuokella (Scott et al., 2000). 
Comparison  of  MICs  and  (GTG)5-PCR  genomic  fingerprinting  data 
showed  that  14  of  the  16  L. reuteri  strains  with  high  MICs  for  both 
ampicillin  and tetracycline displayed highly similar rep-PCR fingerprints. 
Three  strains  of  this so-called group B (Fig. 1 in Paper II) were further 
characterised. According to size, all three strains seemed to carry the same 
four  plasmids  and  a  tet(W)  probe  hybridised  to  the  same  plasmid  of 
approximately 12 kb. We therefore presumed that all strains of group B, 
widely distributed in terms of source and geographical origin, contained the 
same  tetracycline  resistance  plasmid.  The  other  ten  strains  with  atypical 
MIC  for  tetracycline  were  evenly  scattered  throughout  the  dendrogram. 
The  apparent  genetic  heterogeneity  of  these  strains  was  further 
demonstrated by the mixed localisation of the tet(W) gene on plasmids or 
on  the  chromosome,  as  determined  by  Southern  blot  and/or  the    Ct 
PCR method described in detail in Paper IV. 
The conservation of the tet(W) gene sequences from different isolates is 
remarkably high (Scott et al., 2000), as was further confirmed here by the 
sequence  analysis  of  a  chromosome-located  tet(W)  gene  and  a  plasmid-
bound tet(W) gene identified in L. reuteri strains from pig (PA-16) isolated 
in the 1970s and from human breast milk (ATCC 55730) isolated in 1990, 
respectively. The whole 1.9 kb gene differs by only two nucleotides in the 
two L. reuteri strains and by 38 or 40 nucleotides compared with the rumen 
anaerobe  Butyrivibrio  fibrisolvens  (data  not  shown),  where  tet(W)  was  first 
identified on a chromosomal transposon (Barbosa et al., 1999). The regions 
surrounding tet(W) vary in different species of gut bacteria, but contain a 
conserved core region of 2.6 kb, including the resistance gene, as reported 
by Kazimierczak et al. (2006). The flanking regions of the two L. reuteri 
tet(W)  genes  described  in  this  thesis  showed  95-96%  similarity  to  the 
conserved  657-bp  upstream  region,  but  did  not  contain  the  conserved 
43-bp region downstream of tet(W) (Fig. 7). 
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Figure 7. Organisation of the regions surrounding tet(W) of L. reuteri ATCC 55730 (A) and 
L. reuteri PA-16 (B) described in this thesis, and of Butyrvibrio fibrisolvens 1.230 on transposon 
TnB1230  (Melville  et  al.,  2004;  Kazimierczak  et  al.,  2006)  (C).  Grey  arrows  indicate 
pseudogenes. Hyp. = Hypothetical protein; Ars. red. = Arsenite reductase; ArsR = Arsenite 
transcriptional regulator; ACR3 = Arsenite efflux pump; MgtC = MgtC/SapB transporter; * 
= Tet(W)-regulatory peptide; MAFF= a 46-aa protein designated MAFF to represent the 
first four amino acids. In TnB1230, tet(W) is flanked by two identical direct-repeat DNA 
sequences, indicated as diagonal striped rectangular boxes. 
  
Whether the widespread presence of tet(W) in genetically diverse L. reuteri 
strains  is  due  to  repeated  uptake  of  the  gene/plasmid  or  to  a  common 
ancestor becoming tet(W) positive and some strains having lost their tet(W) 
gene over time is an open question. An argument for the former hypothesis 
is that tet(W) has been found in many species present in the gastrointestinal 
tract of both humans and animals (Scott et al., 2000) and is often associated 
with conjugative transposons (Roberts, 2005). Differences with respect to 
flanking  regions  of  the  two  sequenced  tet(W)  genes  would  also  suggest 
multiple independent acquisitions. However, although sequence analysis of 
the 12-kb-plasmid harbouring tet(W) in L. reuteri ATCC 55730 revealed a 
downstream integrase, no known origin of transfer or any described tra or 
mob  genes  were  found.  Alternatively,  only  the  tet(W)  gene  has  been 
transferred.  As  suggested  by  Kazimierczak  et  al.  (2006),  the  conserved   41 
surrounding  region  might  function  as  a  mini  transfer  cassette  that  has 
become incorporated into larger mobile elements. 
4.2.2  Erythromycin resistance in L. reuteri  
Six L. reuteri strains with clearly higher MICs for erythromycin than the 
majority of strains also had atypical MICs for clindamycin, indicating cross-
resistance. Indeed, four of the strains were positive for erm(B) and one strain 
each  was  positive  for  erm(C)  and  erm(T),  as  determined  with  real-time 
PCR. The resulting dimethylation of the overlapping binding site of the 
50S ribosomal subunit confers high resistance to all MLSB antibiotics (Liu & 
Douthwaite, 2002), thus also explaining the increased MICs to dalfopristin-
quinupristin (a mixture of streptogramin A and B). The presence of erm(B) 
was in agreement with previous studies of three (1048, 1068, 8557:1) of the 
erythromycin resistant strains (Axelsson et al., 1988; S. Ahrné, pers. comm. 
2009).   
Comparison  of  MICs  and  (GTG)5-PCR  genomic  fingerprinting  data 
(Fig.  1  in  Paper  IV)  showed  that  the  six  strains  with  atypical  MICs  for 
erythromycin and clindamycin were clustered together in the dendrogram, 
although they did not form a separate group. All erm genes were plasmid-
encoded  and  except  for  erm(B)  in  strains  8557:1  and  1068,  they  were 
located on plasmids of different sizes, as determined by Southern blot (data 
not shown), the   Ct PCR method and/or reported previously (Axelsson 
et al., 1988; S. Ahrné, pers. comm. 2009). The unique plasmid profiles of 
the  erm  positive  strains  imply  that  the  erythromycin  resistance  was  not 
spread clonally, but rather taken up in separate events. 
 Similarly  to  the  L. reuteri  strain  LMG  18391,  the  presence  of  both 
erm(B) and tet(W) has recently been reported in an L. paracasei strain (Huys 
et al., 2008) and two L. crispatus strains (Klare et al., 2007). We found that 
the  two  genes  were  located  on  the  same  plasmid,  as  determined  by 
Southern  blot  (data  not  shown  for  erm(B)).  However,  it  remains  to  be 
determined  whether  the  genes  are  linked  to  a  conjugative  transposon, 
which is often the case with linked erm(B) and tet(M) (Roberts et al., 1999). 
The  other  strain  (PA-16)  with  atypical  MICs  for  both  tetracycline  and 
erythromycin/clindamycin carried tet(W) and erm(C). Sequence analysis of 
the erm(C) gene and its flanking regions by direct genome sequencing and a 
subsequent BLASTP search in Genbank revealed an rRNA methylase with 
high  similarity  (95-99%  amino  acid  identity)  to  erm(C)  genes  present  in 
various Staphylococcus species. The gene, which is usually located on small 
plasmids (<5 kb) in staphylococci, was found in the L. reuteri strain on a 
plasmid of approximately 20 kb. The transposases located downstream of   42 
the erm(C) gene and the chromosome-located tet(W) gene of the same strain 
may be part of transfer machineries, facilitating the spread to other strains. 
The macrolide tylosin was the most commonly used antimicrobial agent 
in pig farming in the European Union until it was banned as an animal 
growth promoter in 1999. Today it is still used for therapeutic purposes 
(A. Franklin,  pers.  comm.  2009).  Consequently,  bacteria  such  as 
enterococci and staphylococci isolated from pigs are frequently resistant to 
macrolides (Aarestrup & Carstensen, 1998). Here, we found that four of the 
six  L. reuteri  strains  that  tested  positive  for  an  erm  gene  were  originally 
isolated from pigs, although only six of the 56 strains tested in this thesis 
were  from  this  source.  In  contrast,  Korhonen  et  al.  (2007)  previously 
reported  that  none  of  the  43  L.  reuteri  strains  isolated  from  30-day-old 
piglets displayed atypical MICs for erythromycin or clindamycin. 
4.3  Antibiotic resistance in L. plantarum (I I I III II II II and I I I IV V V V) 
The susceptibility of up to 121 L. plantarum strains to six antibiotics was 
assessed by Etest and/or broth microdilution (Paper III and Table E1 of the 
preceding  errata  list).  Strains  with  atypical  antibiotic  MICs  were 
subsequently screened by real-time PCR and/or a DNA microarray assay 
for  the  presence  of  known  resistance  genes  (Paper  IV).  Antibiotic 
susceptibility ranges and identified resistance genes are summarised in Table 
3. A uniform MIC distribution was obtained for ampicillin, erythromycin 
and gentamicin, with MICs up to 2 µg/mL, 1-2 µg/mL and 8-16 µg/mL, 
respectively, depending on the method used. For streptomycin, all strains 
had MICs in the upper test range or above the maximum concentration 
tested.  Thus,  further  testing  using  higher  streptomycin  concentrations 
would be needed to define a microbiological breakpoint for L. plantarum to 
this antibiotic. However, the increased MICs, which are probably due to an 
intrinsic trait (Danielsen & Wind, 2003), are in accordance with previous 
results  for  L. plantarum  and  other  Lactobacillus  species,  as  is  the  higher 
observed  susceptibility  to  gentamicin  compared  with  streptomycin 
(Danielsen & Wind, 2003; Korhonen et al., 2008; Paper II). A distribution 
with  MICs  up  to  8 µg/mL,  but  without  a  clear  peak,  was  obtained  for 
clindamycin. The wide range, covering seven log2 dilution steps, could be 
due to interlaboratory discrepancies despite the same protocols being used 
in the four participating laboratories. 
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Table  3.  Antibiotic  susceptibility  ranges  in  terms  of  distribution  of  typical  and  atypical  MICs  for 
L. plantarum obtained by Etest, and identified resistance genes. 
Antibiotic  Wild-type  
MIC range 
(µg/mL) (n) 
Atypical   
MIC range 
(µg/mL) (n) 
Identified resistance genes (n) 
Ampicillin    ≤0.12-2 (66)     
Gentamicin      0.25-8 (66)     
Streptomycin   2->256 (121)     
Erythromycin  ≤0.12-2 (121)     
Clindamycin    ≤0.12-8 (73)     
Tetracycline       2-32 (117)  128->256 (4)  tet(M) (2) 
 
4.3.1  Tetracycline resistance in L. plantarum 
A bimodal distribution of high MICs was obtained for tetracycline with 
both  Etest  and  broth  microdilution.  Four  strains  displayed  a  tetracycline 
MIC  above  64  µg/mL  by  Etest  and  thus  deviated  from  the  wild-type 
population,  which  displayed  MICs  of  up  to  32  µg/mL.  The  genes 
conferring  tetracycline  resistance  in  the  two  strains  isolated  from  Italian 
silage in 1999 were subsequently identified by real-time PCR and localised 
by Southern blot and/or the   Ct PCR method (Paper IV). Both these 
L. plantarum strains displayed the same plasmid profile and were positive for 
tet(M), the most widely distributed tet gene in terms of genera (Roberts, 
2005), including lactobacilli. The tet(M) and tet(S) are the only tet genes 
found so far in L. plantarum  (Danielsen, 2002; Gevers et al., 2003a; Huys et 
al., 2006). When located in this species, tet(M) has been found on a plasmid 
with a size of approx. 10 kb (Danielsen, 2002; Gevers et al., 2003a), which 
was  also  the  case  in  the  present  study.  Thus,  the  two  strains  harboured 
potentially  transferable  resistance  genes  and  should  in  this  regard  not  be 
commercially  used  as  feed  additives  (European  Parliament  and  Council 
Regulation EC 429/2008; EC, 2001).  
The  remaining  two  L. plantarum  strains  with  atypical  MIC  for 
tetracycline were isolated from Italian or Spanish dairy products in 2002. 
One of the strains has not been screened for tetracycline resistance genes, 
whereas the other strain was negative to the tetracycline resistance genes 
tested by the DNA microarray assay (data not shown). 
4.3.2  Tentative microbiological breakpoints for L. plantarum 
The  microbiological  breakpoints  defined  by  EFSA  (2005)  for  lactobacilli 
strains  used  as  feed  additives  are  divided  into  three  categories:   44 
heterofermentative, obligately homofermentive and the species L. plantarum. 
This has been found to be inadequate in many cases, especially for the large 
L. delbrueckii  group  (Korhonen  et  al.,  2008).  Tentative  microbiological 
breakpoints, referred to as susceptibility-resistance cut-off values in Paper 
III, were proposed for L. plantarum to emphasise the need for breakpoints 
for individual LAB species (Paper III and Table E2 of the preceding errata 
list). The L. plantarum breakpoints defined in Paper III and by EFSA were 
conflicting for all antibiotics except tetracycline. Thus, the same four strains 
with atypical MIC for tetracycline were considered resistant using either 
breakpoint, whereas e.g. eight strains that were susceptible to clindamycin 
were considered resistant using the EFSA breakpoints. However, the EFSA 
breakpoints have recently been updated and are now in agreement with the 
cut-offs defined in Paper III using broth microdilution for all antibiotics 
except clindamycin (EFSA, 2008). 
4.4  Phenotypic versus genotypic data (II II II II, III  III  III  III, and       IV IV IV IV) 
The results of the molecular screening correlated well with MIC data on 
L. reuteri  and  L. plantarum,  except  for  one  tet(W)  positive  L. reuteri strain 
with  a  tetracycline  MIC  of  16  µg/mL  and  four  presumably  tet  negative 
L. reuteri strains with atypical tetracycline MIC (≥256 µg/mL). A weaker 
hybridisation  signal  for  the  tet(W)  oligonucleotide  was  observed  on  the 
microarray for the former strain compared with control strains, indicating 
the presence of a partial or mutated tet(W) gene, or a gene that is similar, 
rather than identical to tet(W). Sequence analysis of the tet(W) gene in this 
phenotypically  susceptible  strain  could further  elucidate  why  the  gene  is 
non-functional. 
Two of the four strains with atypical tetracycline MIC were also tested 
by microarray analysis, but were negative to the 33 tet genes included in the 
array.  For  these  strains,  there  might  be  other  underlying  resistance 
mechanisms  such  as  the  presence  of  multidrug  efflux  pumps  removing 
tetracycline  from  its  target,  as  has  previously  been  demonstrated  in 
bifidobacteria for other antibiotics (Margolles et al., 2006). In either case, 
this  shows  that  phenotypic  and  molecular  tools  are  both  needed  to 
guarantee  the  presence  or  absence  of  acquired  resistance  genes  in strains 
intended for use in food, feed and probiotic applications, as has also been 
pointed out by others (Hummel et al., 2007; van Hoek et al., 2008).   45 
4.5  In vivo transferability of an L. reuteri tet(W) gene (V V V V)  
As stated in the introduction, the potential contribution of lactobacilli to the 
spread of antibiotic resistance genes in the human gut is poorly addressed. 
We  therefore  investigated  the  transferability  of  the  tetracycline resistance 
gene  tet(W) from the formerly commercially available probiotic L. reuteri 
strain  ATCC 55730  to  bacteria  in  the  intestinal  tract  of  humans.  In  a 
double-blind  clinical  study,  seven  subjects  consumed  L. reuteri 
ATCC 55730 harbouring a plasmid-encoded tet(W) gene (tet(W)-reuteri). 
The control group of seven other subjects consumed L. reuteri DSM 17938 
derived from the ATCC 55730 strain by the removal of two plasmids (Fig. 
8), one of which contained the tet(W)-reuteri gene (Rosander et al., 2008). 
 
 
Figure 8. The commercial probiotic L. reuteri DSM 17938 was derived from L. reuteri ATCC 
55730 by the removal of two resistance plasmids, pLR581 harbouring a tet(W) gene (A) and 
pLR585 harbouring an lnu(A) gene (B).   46 
In total, 5 × 10
8 CFU of L. reuteri were ingested in the form of chewable 
tablets  each  day  for  14  days  and  faecal  samples  were  collected  on  four 
occasions on Days -7 and 0 (baseline), 14 and 28, i.e. after a two-week 
washout period (Fig. 9). 
 
 
 
Figure  9.  Probiotic  intake  (shaded 
field) and collection of faecal samples 
(arrows). 
 
Both L. reuteri strains were detectable at similar levels in faeces by culture 
after 14 days of ingestion in 13 of the 14 subjects, but not after a two-week 
washout period, indicating that the strains survive but are only transiently 
present  in  the  intestine.  Colonisation  of  the  human  gastrointestinal  tract 
would  increase  the  probability  of  donor-recipient  encounters  facilitating 
gene exchange, but temporary presence of the donor bacteria is sufficient 
for conjugative gene transfer to occur at least, as reviewed by Licht & Wilks 
(2006). The tet(W)-reuteri plasmid appears to be non-conjugative and non-
mobilisable  (Paper  IV).  Furthermore,  the  risk  of  horizontal  transfer  by 
transformation in the gastrointestinal tract is regarded as negligible (van den 
Eede  et  al.,  2004).  However,  several  phage  related  genes  have  been 
identified in the draft genome sequence of the ATCC 55730 strain (Båth et 
al., 2005; H. Jonsson, pers. comm. 2009), thus not excluding transduction 
as a possible mechanism of transfer. 
To distinguish between tet(W)-reuteri and tet(W) genes present in the 
faecal microbiota, a real-time PCR method for allelic discrimination was 
developed  in  Paper  V  (Fig.  10).  This  was  necessary  due  to  the  wide 
distribution  of  tet(W)  in  different  bacterial  species  of  human  faeces  in 
combination  with  the  high  conservation  of  tet(W)  nucleotide  sequences 
from different isolates (Scott et al., 2000; Kazimierczak et al., 2006; Paper 
IV). A tet(W)-reuteri or tet(W) signal produced for two strains harbouring 
either  type  of  gene  showed  that  the  method  could  be  used  for 
distinguishing between the tet(W) gene types. However, testing different 
ratios of tet(W)-reuteri to tet(W) showed that a tet(W)-reuteri signal was 
detectable in the presence of a 100-fold higher concentration of tet(W) but 
not  in  a  1000-fold  higher  concentration.  Furthermore,  a  tet(W)-reuteri 
signal was produced from the faecal L. reuteri isolates tested of those subjects 
Day   -7 0 7        14        28
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having ingested the tet(W)-positive strain. Thus the method could be used 
to detect the gene in faecal material. 
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Figure 10. Principle of the real-time PCR allelic discrimination method developed in Paper 
V. The technique is dependent on the competition between two probes labelled with the 
same quenching fluorophor but different reporter fluorophors, VIC and FAM. The VIC 
probe was specific for tet(W)-reuteri, with an A in position 109 of the resistance gene (A) 
and the FAM probe was specific for other previously described tet(W) genes, with a G in 
that position (B). During PCR-amplification, primers (not shown) and the exact-matched 
probe bind and the probe is subsequently hydrolysed by the endonuclease activity of the Taq 
polymerase.  This  releases  the  corresponding  reporter  fluorophor  from  its  quencher  and 
results in an increase in VIC or FAM fluorescence, i.e. a tet(W)-reuteri or tet(W) signal. The 
design of primers and probes is described in detail in Paper V.   48 
After  enrichment  and  isolation  of  bacterial  colonies  in/on  genus-specific 
tetracycline supplemented media, DNA was extracted and the presence of 
tet(W)-reuteri was screened by the real-time PCR method developed. A 
lower Ct value compared with the baseline and the control group obtained 
by the tet(W)-reuteri detector for the Day 14 and/or Day 28 faecal sample 
DNA  from  a  subject  having  ingested  tet(W)  positive  L. reuteri  would 
indicate tet(W)-reuteri gene transfer. However, no tet(W)-reuteri signal was 
produced  from  any  of  the  DNA  samples.  Thus  no  transfer  events  were 
demonstrated  under  the  conditions  tested,  suggesting  that  transfer of the 
tet(W)-reuteri gene during intestinal passage of the probiotic L. reuteri did 
not occur or occurred at low frequencies undetectable by the method used. 
As indicated by the tet(W) signals produced, this gene was present in the 
faecal material from all subjects on one or more sampling occasions, thus 
verifying  its  common  occurrence  within  the  tetracycline  resistant  faecal 
populations of the three genera investigated. 
An  additional  objective  was  to  assess  the  proportion  of  tetracycline 
resistant enterococci, bifidobacteria and lactobacilli present in faeces. The 
baseline level was 5-12% for one of the eight subjects tested, but in most 
cases it was less than 0.1%. Our results are in agreement with findings from 
a similar study in Finland by Saarela et al. (2007), but in contrast to previous 
findings on the antibiotic susceptibility of faecal strains in Spain, France and 
Denmark, which suggested a high natural prevalence of tetracycline resistant 
bifidobacteria, lactobacilli and enterococci in human faeces (Aarestrup et al., 
2000; Delgado et al., 2005; Moubareck et al., 2005). Variation in antibiotic 
use could be a plausible explanation for the higher levels observed in France 
and Spain (Cars et al., 2001).   49 
5   Conclusions 
The main findings of this thesis were: 
 
   Controlled  and  standardised  conditions  are  required  for  antibiotic 
susceptibility testing of LAB. 
   Increased  inoculum  size  or  extended  incubation  time  resulted  in 
elevated  antibiotic  MICs  for  all  LAB  strains  using  broth 
microdilution. 
   An inoculum of 3 × × × × 10
5 CFU/mL and an incubation time of 48 h 
were recommended for assessing the antibiotic susceptibility of LAB 
by this method.  
   The  results  obtained  have  contributed  to  the  development  of  an 
international ISO standard method for broth microdilution. 
   The MIC data obtained with the Etest and the broth microdilution 
method were in close agreement for both L. reuteri and L. plantarum. 
 
   All  L. plantarum  strains  tested  (n=121)  were  susceptible  to  ampicillin, 
gentamicin, erythromycin and clindamycin, and intrinsically resistant to 
streptomycin.  Acquired  resistance  to  tetracycline  was  associated  with 
plasmid-bound tet(M). 
 
   The members of L. reuteri tested (n=56) were susceptible to linezolid, 
trimethoprim and the aminoglycosides gentamicin and netilmycin, and 
intrinsically resistant to vancomycin and the aminoglycosides amikacin, 
kanamycin and streptomycin. 
 
   Lactobacillus reuteri strains with atypical MICs for both tetracycline and 
ampicillin  were  linked  to  the  same  genotype,  and  the  strains  with   50 
atypical  MICs  for  erythromycin  and  clindamycin  were  clustered 
together, although not forming a separate group. 
 
   Lactobacillus reuteri strains had acquired resistance to tetracycline (n=28), 
ampicillin  (n=14),  erythromycin/clindamycin  (n=6),  and 
chloramphenicol (n=1). This resistance was attributed to mutational pbp 
genes for ampicillin and to added tet(W), erm and cat(TC) genes for the 
antibiotics inhibiting protein synthesis.    
 
   The  majority  of  the  antibiotic  resistant  L. reuteri  strains  harboured 
plasmid-encoded resistance genes. Traits of putative transfer machineries 
adjacent  to  both  plasmid-  and  chromosome-located  resistance  genes 
were demonstrated. 
 
   A maximum of two acquired resistance genes were found per L. reuteri 
strain. 
 
   Transfer  of  the  tet(W)  gene  from  the  probiotic  strain  L. reuteri 
ATCC 55730  to  faecal enterococci, bifidobacteria and lactobacilli was 
non-detectable  under  the  conditions  tested,  although  transfer  at  low 
frequencies cannot be excluded. 
5.1  Future perspectives 
LAB  intentionally  added  to  the  food  chain  should  not  carry  transferable 
antibiotic resistance genes (EFSA, 2007). In the absence of reliable scientific 
data on the potential transfer of antibiotic resistant LAB strains, such strains 
should be avoided as food processing aids and probiotics according to the 
precautionary  principle.  This  thesis  provides  data  required  to  assess  the 
possible risk of using antibiotic resistant strains of the LAB species L. reuteri 
and  L. plantarum  as  starter  cultures  or  probiotics.  However,  more  data 
would be of value for further assessment. In particular, more transferability 
studies  in  the  human  gut  of  both  conjugative  and  non-conjugative 
antibiotic  resistance  plasmids/transposons  are  needed  to  determine  the 
potential  for  horizontal  transfer.  In  my  opinion,  such  studies  should 
primarily focus on erm positive lactobacilli due to the clinical importance of 
macrolides.  Sequencing  of  flanking  regions  of  the  remaining  plasmid-
encoded  or  chromosome-located  tet(W)  genes  found  in  L. reuteri  could 
reveal more about the acquisition of this apparently common gene within 
this species.   51 
The  considerable  increase  in  available  antibiotic  susceptibility  data  for 
lactobacilli through e.g. ACE-ART (Korhonen et al., 2008) and PROSAFE 
(Klare et al., 2007) resulted in an recent update of the EFSA breakpoints for 
LAB used as feed additives and a subsequent split-up of the breakpoints for 
individual  LAB  species  (EFSA,  2008).  A  regulation  for  LAB  added  to 
fermented food and probiotics for human use will probably be proposed in 
the near future. Imposed restrictions have to be based on scientific data, 
such  as  these,  so  that  the  current  strategy  based  on  the  precautionary 
principle can be proven or discounted. Phenotypic tests and molecular tools 
are  both  needed  to  scientifically  guarantee  the  presence  or  absence  of 
acquired resistance genes in potential starter/probiotic candidates, as pointed 
out  in  this thesis and by others (Hummel et al., 2007; van Hoek et al., 
2008). 
The MIC data presented in this thesis in combination with the results of 
others will hopefully be used for risk management strategies by organisations 
such  as  EUCAST  to  define  rational  microbiological  breakpoints  for  the 
species L. reuteri and L. plantarum. In this thesis, the antibiotics included in 
the  susceptibility  testing  were  those recommended at the time by EFSA 
(2005). Resistance to quinolones and third/fourth- generation cefalosporins 
has,  as  previously  mentioned,  been  reported  as  an  intrinsic  feature  in 
lactobacilli. In my opinion, these antibiotics should potentially be tested on 
a  number  of  Lactobacillus  species  as  more  pathogenic  bacteria  become 
resistant to the clinically important antibiotics. 
Finally, antibiotic resistance of LAB could also be regarded as a beneficial 
property.  A  resistant  probiotic  strain  that  is  co-administered  with  an 
antibiotic may reduce the gastrointestinal side effects related to antibiotic 
treatment (Courvalin, 2006). By identifying strains with potentially non-
transferable  resistance  genes,  this  field  of  application  might  gain  wider 
acceptance and thus have a greater impact in the future.   52   53 
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